Quidel, a diagnostic testing solutions provider, has received CE mark approval for its Sofia strep A fluorescent immunoassay (FIA) test for use with its Sofia analyser.

The Sofia analyser and Sofia strep A FIA integrates lateral flow technology, fluorescent chemistry, failure alert and fail-safe systems to provide accurate diagnostic result.

Quidel president and CEO Douglas Bryant said in combination with their Sofia influenza A+B FIA, Sofia strep A FIA will provide healthcare providers with added testing versatility during this respiratory disease season.